Posted in | News | Biofuels | Renewable Energy

Porta Hnos Inks Letter of Intent to Become Exclusive Licensee of Gevo's GIFT Technology to Produce Isobutanol

Gevo, Inc., the world's only commercial producer of renewable isobutanol, announced today that Porta Hnos S.A. ("Porta") has signed a letter of intent to become the exclusive licensee of GIFT® in Argentina to produce renewable isobutanol.

"Isobutanol's versatility and hydrocarbon-like properties make it an ideal renewable fuel and chemical for Argentina and Gevo's GIFT® technology is the most efficient way to produce it," said Fernando Porta, Vice President of Porta. "Porta is already a leading ethanol producer in Argentina and we would like to expand our footprint to other high-value renewable alcohols such as isobutanol."

Porta is a 132 year old family owned company in Argentina that produces liquor, vinegars and has a 120 m3/day corn ethanol plant. In addition, Porta has designed and built two 250 m3/day ethanol plants for others and they are working on 2 more ethanol plants for 2014. Half of all current ethanol plants in Argentina were designed by Porta, and they have a joint venture with Alpha Laval to provide separation and evaporation expertise.

"Commercial licensing of our GIFT® technology in the US and abroad is the next step in Gevo's business model and we are very pleased to be working in Argentina with an industry leader like Porta," said Patrick Gruber, Gevo's chief executive officer. "Commercial licenses demonstrate the value of Gevo's GIFT® technology to the market place and enables a low-capital route to building out renewable isobutanol capacity globally."

About Gevo

Gevo is a leading renewable chemicals and next-generation biofuels company. Gevo's patent-protected, capital-light business model converts existing ethanol plants into bio-refineries to make isobutanol. This versatile chemical can be directly integrated into existing chemical and fuel products to deliver environmental and economic benefits. Gevo has executed initial commercial-scale production runs at its isobutanol facility in Luverne, Minn., constructed in conjunction with ICM, a leading provider of proprietary ethanol process technology, and has a marquee list of partners including The Coca-Cola Company, Sasol Chemical Industries, and LANXESS, Inc., an affiliate of LANXESS Corporation, among others. Gevo is committed to a sustainable bio-based economy that meets society's needs for plentiful food and clean air and water. For more information, visit www.gevo.com.

About Porta Hnos S.A.

Porta Hnos is one of the leading alcohols companies in Argentina, producing almost 100 million liters annually. Porta Hnos is diversified across 6 independent divisions: Alcohol, Beverages, Distillery, Softeners, Vinegars & Balsamic Vinegars and Porta Engineering. Porta Hnos was founded in Córdoba, Argentina, by Italian immigrants in the 1882, and now is directed by fourth generation family members and employs over 350 people. For more information, visit http://en.portahnos.com.ar.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Gevo. (2019, March 01). Porta Hnos Inks Letter of Intent to Become Exclusive Licensee of Gevo's GIFT Technology to Produce Isobutanol. AZoCleantech. Retrieved on November 24, 2024 from https://www.azocleantech.com/news.aspx?newsID=19784.

  • MLA

    Gevo. "Porta Hnos Inks Letter of Intent to Become Exclusive Licensee of Gevo's GIFT Technology to Produce Isobutanol". AZoCleantech. 24 November 2024. <https://www.azocleantech.com/news.aspx?newsID=19784>.

  • Chicago

    Gevo. "Porta Hnos Inks Letter of Intent to Become Exclusive Licensee of Gevo's GIFT Technology to Produce Isobutanol". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=19784. (accessed November 24, 2024).

  • Harvard

    Gevo. 2019. Porta Hnos Inks Letter of Intent to Become Exclusive Licensee of Gevo's GIFT Technology to Produce Isobutanol. AZoCleantech, viewed 24 November 2024, https://www.azocleantech.com/news.aspx?newsID=19784.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.